5[3]Flockhart DA, Tanus Santos JE.Implications of cytochrome P45o interactions when prescribing medication for hypertension[J].Ach Intern Med, 2000,162:405.
6[4]Sica DA.Rationale for fixed-dose combinations in the treatment of hypertension[J]. Drugs, 2002, 62:443.
7[5]Venkatakrishnan K.Von Moltke LL,Greenblatt DJ.Humen drug metabolism and the cytochromes P450:Application and relevance of in vitro models [J].J Clin Pharmacol,2001,41:1 149.
8千葉宽.药物代谢酵素の遗传的多型と临床的意义[J].药局,1999,(50):36.
9东纯一,山本勇.遗传子多型と降压药の选择[J].综合临床,2000,(3):457.
10[9]Bailey D, Edger B,Spence JD, et al. Felodipine and nifedipine interactions with grapefruit juice[J]. Clin Pharmacol Therap, 1990,47: 180.
